Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 100%

Tumour response · people with cutaneous melanoma

MEK inhibitors leads to higher tumour response compared with chemotherapy (high certainty).

1 finding from 1 review

Systemic treatments for metastatic cutaneous melanoma 2018 · Cochrane Headline outcomes only
RR 2.01 [1.35, 2.99]
496 participants
High

Tumour response · people with cutaneous melanoma

BRAF plus MEK inhibitors leads to higher tumour response compared with BRAF inhibitors (high certainty).

1 finding from 1 review

Systemic treatments for metastatic cutaneous melanoma 2018 · Cochrane Headline outcomes only
RR 1.32 [1.2, 1.46]
1784 participants
High